441 related articles for article (PubMed ID: 22337830)
1. Triangulated mal-signaling in Alzheimer's disease: roles of neurotoxic ceramides, ER stress, and insulin resistance reviewed.
de la Monte SM
J Alzheimers Dis; 2012; 30 Suppl 2(0 2):S231-49. PubMed ID: 22337830
[TBL] [Abstract][Full Text] [Related]
2. Metabolic derangements mediate cognitive impairment and Alzheimer's disease: role of peripheral insulin-resistance diseases.
De La Monte SM
Panminerva Med; 2012 Sep; 54(3):171-8. PubMed ID: 22801434
[TBL] [Abstract][Full Text] [Related]
3. Dysfunctional pro-ceramide, ER stress, and insulin/IGF signaling networks with progression of Alzheimer's disease.
de la Monte SM; Re E; Longato L; Tong M
J Alzheimers Dis; 2012; 30 Suppl 2(0 2):S217-29. PubMed ID: 22297646
[TBL] [Abstract][Full Text] [Related]
4. Insulin resistance, ceramide accumulation, and endoplasmic reticulum stress in human chronic alcohol-related liver disease.
Longato L; Ripp K; Setshedi M; Dostalek M; Akhlaghi F; Branda M; Wands JR; de la Monte SM
Oxid Med Cell Longev; 2012; 2012():479348. PubMed ID: 22577490
[TBL] [Abstract][Full Text] [Related]
5. Insulin resistance, ceramide accumulation and endoplasmic reticulum stress in experimental chronic alcohol-induced steatohepatitis.
Ramirez T; Longato L; Dostalek M; Tong M; Wands JR; de la Monte SM
Alcohol Alcohol; 2013; 48(1):39-52. PubMed ID: 22997409
[TBL] [Abstract][Full Text] [Related]
6. Contributions of brain insulin resistance and deficiency in amyloid-related neurodegeneration in Alzheimer's disease.
de la Monte SM
Drugs; 2012 Jan; 72(1):49-66. PubMed ID: 22191795
[TBL] [Abstract][Full Text] [Related]
7. Ceramide-mediated insulin resistance and impairment of cognitive-motor functions.
de la Monte SM; Tong M; Nguyen V; Setshedi M; Longato L; Wands JR
J Alzheimers Dis; 2010; 21(3):967-84. PubMed ID: 20693650
[TBL] [Abstract][Full Text] [Related]
8. Insulin resistance and neurodegeneration: roles of obesity, type 2 diabetes mellitus and non-alcoholic steatohepatitis.
de la Monte SM; Longato L; Tong M; Wands JR
Curr Opin Investig Drugs; 2009 Oct; 10(10):1049-60. PubMed ID: 19777393
[TBL] [Abstract][Full Text] [Related]
9. Deciphering the Link Between Hyperhomocysteinemia and Ceramide Metabolism in Alzheimer-Type Neurodegeneration.
Le Stunff H; Véret J; Kassis N; Denom J; Meneyrol K; Paul JL; Cruciani-Guglielmacci C; Magnan C; Janel N
Front Neurol; 2019; 10():807. PubMed ID: 31417486
[TBL] [Abstract][Full Text] [Related]
10. Brain metabolic dysfunction at the core of Alzheimer's disease.
de la Monte SM; Tong M
Biochem Pharmacol; 2014 Apr; 88(4):548-59. PubMed ID: 24380887
[TBL] [Abstract][Full Text] [Related]
11. Insulin resistance and Alzheimer's disease.
de la Monte SM
BMB Rep; 2009 Aug; 42(8):475-81. PubMed ID: 19712582
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic reversal of chronic alcohol-related steatohepatitis with the ceramide inhibitor myriocin.
Tong M; Longato L; Ramirez T; Zabala V; Wands JR; de la Monte SM
Int J Exp Pathol; 2014 Feb; 95(1):49-63. PubMed ID: 24456332
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of ceramide-mediated neurodegeneration.
Tong M; de la Monte SM
J Alzheimers Dis; 2009; 16(4):705-14. PubMed ID: 19387107
[TBL] [Abstract][Full Text] [Related]
14. Hepatic ceramide may mediate brain insulin resistance and neurodegeneration in type 2 diabetes and non-alcoholic steatohepatitis.
Lyn-Cook LE; Lawton M; Tong M; Silbermann E; Longato L; Jiao P; Mark P; Wands JR; Xu H; de la Monte SM
J Alzheimers Dis; 2009; 16(4):715-29. PubMed ID: 19387108
[TBL] [Abstract][Full Text] [Related]
15. The liver-brain axis of alcohol-mediated neurodegeneration: role of toxic lipids.
de la Monte SM; Longato L; Tong M; DeNucci S; Wands JR
Int J Environ Res Public Health; 2009 Jul; 6(7):2055-75. PubMed ID: 19742171
[TBL] [Abstract][Full Text] [Related]
16. Cigarette smoke exposure impairs β-cell function through activation of oxidative stress and ceramide accumulation.
Tong X; Chaudhry Z; Lee CC; Bone RN; Kanojia S; Maddatu J; Sohn P; Weaver SA; Robertson MA; Petrache I; Evans-Molina C; Kono T
Mol Metab; 2020 Jul; 37():100975. PubMed ID: 32283079
[TBL] [Abstract][Full Text] [Related]
17. Chronic alcohol-induced hepatic insulin resistance and endoplasmic reticulum stress ameliorated by peroxisome-proliferator activated receptor-δ agonist treatment.
Ramirez T; Tong M; Chen WC; Nguyen QG; Wands JR; de la Monte SM
J Gastroenterol Hepatol; 2013 Jan; 28(1):179-87. PubMed ID: 22988930
[TBL] [Abstract][Full Text] [Related]
18. Central ceramide-induced hypothalamic lipotoxicity and ER stress regulate energy balance.
Contreras C; González-García I; Martínez-Sánchez N; Seoane-Collazo P; Jacas J; Morgan DA; Serra D; Gallego R; Gonzalez F; Casals N; Nogueiras R; Rahmouni K; Diéguez C; López M
Cell Rep; 2014 Oct; 9(1):366-377. PubMed ID: 25284795
[TBL] [Abstract][Full Text] [Related]
19. Alcohol, insulin resistance and the liver-brain axis.
de la Monte S; Derdak Z; Wands JR
J Gastroenterol Hepatol; 2012 Mar; 27 Suppl 2(0 2):33-41. PubMed ID: 22320914
[TBL] [Abstract][Full Text] [Related]
20. Targeting endoplasmic reticulum stress in insulin resistance.
Salvadó L; Palomer X; Barroso E; Vázquez-Carrera M
Trends Endocrinol Metab; 2015 Aug; 26(8):438-48. PubMed ID: 26078196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
